Cargando…
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
BACKGROUND: RAD51 associated protein 1 (RAD51AP1) is shown to regulate cell proliferation and cancer progression. However, the immune-infiltrating correlation and the therapeutics guidance of RAD51AP1 in hepatocellular carcinoma (HCC) still need further investigation. METHODS: In this study, compreh...
Autores principales: | Wei, Yongguang, Lan, Chenlu, Wang, Xiangkun, Zhou, Xin, Liao, Xiwen, Huang, Huasheng, Wei, Zhongliu, Li, Tianman, Peng, Tao, Zhu, Guangzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543100/ https://www.ncbi.nlm.nih.gov/pubmed/37789880 http://dx.doi.org/10.2147/IJGM.S431206 |
Ejemplares similares
-
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022) -
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Lan, Chenlu, et al.
Publicado: (2023) -
SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023) -
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
por: Wei, Yongguang, et al.
Publicado: (2023) -
RAD51AP1 mediates RAD51 activity through nucleosome interaction
por: Pires, Elena, et al.
Publicado: (2021)